on Marinomed Biotech AG
Marinomed Biotech AG Announces Closure Following Insolvency
On September 24, 2026, Marinomed Biotech AG, based in Korneuburg, Austria, disclosed the cessation of its operations due to insolvency. The company's administrator, Dr. Ulla Reisch, initiated the closure process during a court hearing.
The decision follows unsuccessful attempts to maintain operations. Plans for a licensing rights sale failed to materialize in time, and negotiations with prospective investors did not yield positive outcomes. As a result, the insolvency court ordered the business to close.
The insolvency administrator will proceed with selling the company's assets. Marinomed Biotech AG has committed to providing updates on subsequent legal and operational initiatives as new information becomes available.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Marinomed Biotech AG news